LB PharmaceuticalsLBRX
13F holders, Q3 2025 (September 30)53holders
2famous investors
$15.79avg. 13F price*
At the end of Q3 2025, 53 institutions reported holding LB Pharmaceuticals Inc. (LBRX) in their 13F filings. The largest holders were Deep Track Capital, LP ($52.9M), Ra Capital Management, L.P. ($28.1M) and TCG Crossover Management, LLC ($27.6M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- LB Pharmaceuticals Inc.
- CUSIP
- 50180M108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 53 | $314.9M |
| Exits | 0 | $0 |
Ownership 53 holders
| Deep Track Capital, LP | 1.48% | New | 3,352,804 | $52.9M |
| Ra Capital Management, L.P. | 0.35% | New | 1,776,958 | $28.1M |
| TCG Crossover Management, LLC | 1.36% | New | 1,745,016 | $27.6M |
| Commodore Capital LP | 1.16% | New | 1,500,000 | $23.7M |
| Logos Global Management LP | 1.76% | New | 1,130,000 | $17.8M |
| JPMorgan Chase & Co. | 0.00% | New | 1,032,603 | $16.3M |
| BlackRock, Inc. | 0.00% | New | 975,000 | $15.4M |
| Balyasny Asset Management L.P. | 0.03% | New | 968,274 | $15.3M |
| Vivo Capital, LLC | 1.02% | New | 800,000 | $12.6M |
| Jennison Associates LLC | 0.01% | New | 739,040 | $11.7M |
| Nantahala Capital Management, LLC | 0.66% | New | 675,000 | $10.7M |
| Alyeska Investment Group, L.P. | 0.03% | New | 675,000 | $10.7M |
| Citadel Advisors | 0.01% | New | 539,370 | $8.5M |
| Millennium Management | 0.01% | New | 538,169 | $8.5M |
| Soleus Capital Management, L.P. | 0.34% | New | 400,000 | $6.3M |
| FMR LLC | 0.00% | New | 369,100 | $5.8M |
| Wellington Management Group LLP | 0.00% | New | 344,657 | $5.4M |
| Goldman Sachs Group Inc. | 0.00% | New | 343,523 | $5.4M |
| Nan Fung Group Holdings Ltd | 7.95% | New | 300,000 | $4.7M |
| T. Rowe Price Associates Inc. | 0.00% | New | 282,644 | $4.5M |
| Marshall Wace, LLP | 0.00% | New | 255,526 | $4.0M |
| Baker Bros. Advisors LP | 0.02% | New | 200,000 | $3.2M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | New | 200,000 | $3.2M |
| Integral Health Asset Management, LLC | 0.12% | New | 100,000 | $1.6M |
| Ameriprise Financial Inc. | 0.00% | New | 77,450 | $1.2M |
| Boxer Capital Management, LLC | 0.35% | New | 70,000 | $1.1M |
| Silverarc Capital Management, LLC | 0.16% | New | 70,000 | $1.1M |
| HRT Financial LP | 0.00% | New | 58,815 | $928K |
| Monashee Investment Management LLC | 0.33% | New | 40,000 | $632K |
| TD Asset Management Inc | 0.00% | New | 36,780 | $581K |
| Point72 (DIFC) Ltd | 0.04% | New | 34,003 | $537K |
| Barclays PLC | 0.00% | New | 30,839 | $487K |
| Jane Street Group, LLC | 0.00% | New | 30,345 | $479K |
| Acuta Capital Partners, LLC | 0.49% | New | 30,000 | $474K |
| Hudson Bay Capital Management LP | 0.00% | New | 27,097 | $428K |
| Squarepoint Ops LLC | 0.00% | New | 20,825 | $329K |
| Oxford Asset Management LLP | 0.09% | New | 17,763 | $280K |
| Manufacturers Life Insurance Company, The | 0.00% | New | 17,488 | $276K |
| Aristeia Capital, L.L.C. | 0.01% | New | 15,270 | $241K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.04% | New | 14,535 | $230K |
| Quantessence Capital LLC | 0.07% | New | 14,225 | $225K |
| Geode Capital Management, LLC | 0.00% | New | 13,591 | $215K |
| Two Sigma Investments, LP | 0.00% | New | 13,500 | $213K |
| Brevan Howard Capital Management LP | 0.00% | New | 13,259 | $209K |
| Jefferies Financial Group Inc. | 0.00% | New | 13,100 | $207K |
| XTX Topco Ltd | 0.01% | New | 11,276 | $178K |
| Landscape Capital Management, L.L.C. | 0.01% | New | 10,638 | $168K |
| Morgan Stanley | 0.00% | New | 9,605 | $152K |
| Federated Hermes, Inc. | 0.00% | New | 9,000 | $142K |
| Bank of America Corp. | 0.00% | New | 1,700 | $27K |
| UBS Group AG | 0.00% | New | 1,055 | $17K |
| Wells Fargo & Company | 0.00% | New | 1,000 | $16K |
| Quarry LP | 0.00% | New | 11 | $174 |
"% of holder's portfolio" is LBRX's weight in each manager's 13F, not the share of LB Pharmaceuticals Inc. the manager owns.